Not Yet Recruiting A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease NCT07553377 Conditions Alcohol Associated Liver Disease, Alcohol Use Disorder, Alcohol-Related Disorders, +12 more Locations Yale — New Haven, Connecticut, United States View Trial Details
